TME |
Tumor microenvironment |
MSCs |
Mesenchymal stem cells |
CAFs |
Cancer-associated fibroblasts |
CSCs |
cancer stem cells |
NK |
natural killer |
TEXs |
Tumor-derived exosomes |
TAAs |
Tumor-associated antigens |
HCC |
human hepatocellular carcinoma |
ECA |
esophageal carcinoma tissue |
KIRs |
killer immunoglobulin receptors |
NCRs |
natural cytotoxicity receptors |
AML |
acute myelogenous leukaemia |
TAMs |
Tumor-associated macrophages |
EGCG |
epigallocatechin gallate |
DDS |
drug delivery systems |
PAC |
paclitaxel |
TRCs |
tumor-repopulating cells |
CTCs |
circulating tumor cells |
PTC |
papillary thyroid cancer |
CRC |
colorectal cancer |
HSP70 |
heat shock protein 70 |
TSP1 |
platelet-reactive protein 1 |
LDH-C4 |
lactate dehydrogenase C4 |
FDA |
Food and Drug Administration |
PPIs |
proton-pump inhibitors |
GC |
gastric cancer |
PC |
pancreatic cancer |
HSPGs |
Heparan sulfate proteoglycans |
NPC |
nasopharyngeal carcinoma |
FGF |
fibroblast growth factor |
GC-Exos |
Gastric cancer cell-derived exosomes |
CAFs |
Carcinoma-associated fibroblasts |